SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as investors debate its valuation and future growth prospects following recent commentary about branded checkout growth. Community sentiment appears mixed, with some expressing frustration with the stock's performance while others point to potential catalysts like buybacks and AI initiatives. Discussions also revolve around the impact of management communication and broader competition in the fintech sector.

Breaking Bread is a pioneer in Solana meme token designed around a simple and transparent rewards system. With 0% tax on trades, every holder benefits directly from activity without hidden costs or penalties. The token automatically redistributes 100% of creator rewards from Pump.fun back to the community, ensuring fair participation for all holders. The project emphasizes consistency, trust, and community engagement, framing daily “breaking of bread” rewards as both a symbolic ritual and a practical way to sustain value for those who participate.

Breaking Bread

Breaking Bread ($BRBR) is trending due to its innovative approach as a Solana meme coin that rewards holders with $SOL directly, funded by creator rewards and facilitated by zero transaction taxes, which is fueling community excitement and attracting traders seeking real yield. The community is actively discussing the consistent growth, strong floor, and the upcoming feature on CryptoTwits X Spaces, highlighting the project's commitment and potential for long-term gains. Many community members feel this is a refreshing take on meme coins, as it has a true community and rewards for holding.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders weigh potential market volatility amid concerns about Japan's rising bond yields and their impact on global markets. Community discussions revolve around hedging strategies and potential market corrections, with some anticipating a 'black swan' event. Others believe the current market strength is artificial, driven by factors like automated 401k investments, and are positioning for a downturn.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as investors digest recent earnings and guidance, with community discussion focused on the impact of AI and the company's long-term growth strategy. While some express concerns about the stock's performance and management, others see a buying opportunity based on the company's fundamentals and potential for future growth in the AI space. Options activity and analyst ratings are also being closely monitored for further insights.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to positive preclinical data for its intranasal naloxone hydrogel, with the community noting its potential as a multi-day runner. Community members are actively discussing price targets and potential short squeezes, drawing comparisons to other low-float Israeli stocks that have recently experienced significant gains. However, some are expressing caution due to the company's history of reverse splits and dilution, as well as an upcoming clinical trial not expected to start until 2026.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE is trending as the community rallies around its association with AI and Elon Musk. Described as the first AI dog and Grok's companion, BYTE is generating buzz with community members expressing bullish sentiment and anticipation for upcoming developments. The coin is seeing increased attention with some calling it the next SHIB.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending following a partnership announcement with Palantir, integrating their AI platforms. The collaboration aims to enhance data analysis and AI application development, prompting bullish sentiment. Community members are discussing the potential impact on growth, with analysts also weighing in on the partnership's implications.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

AEVA is trending due to a recent partnership with LG Innotek for LiDAR technology development, sparking discussions about its potential in automotive and other sectors. The community is weighing its high valuation against its growth prospects, comparing it to competitors like INVZ and OUST. Some investors are expressing concerns about cash burn and insider selling, while others remain bullish on its technology and long-term potential.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai ($AI) is trending amid discussions around its valuation compared to peers and potential for a short squeeze, as well as speculation about a possible acquisition. Community members are weighing the company's financials and contracts, with some expressing bullish sentiment and others remaining skeptical about its long-term prospects. Option activity and potential price movements are also being closely monitored by traders.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending after releasing positive Phase 3 trial results for their DMD treatment, showing statistically significant improvement in both skeletal and cardiac function. The community is buzzing about the potential for FDA approval and a possible buyout by a major pharmaceutical company, with many expressing excitement about the implications for treating this rare disease. Short sellers are feeling the squeeze, as the stock experiences high volatility and a surge in trading volume.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NeoGenomics, Inc. $NEO Shares Bought by Samjo Management LLC

Samjo Management LLC grew its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 11.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities...

American Century Companies Inc. Has $25.71 Million Stock Position in NeoGenomics, Inc. $NEO

American Century Companies Inc. raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 6.0% during the 2nd quarter, according to the company in its most recent disclosure with the...

Insider Selling: NeoGenomics (NASDAQ:NEO) EVP Sells 20,916 Shares of Stock

NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) EVP Alicia Olivo sold 20,916 shares of the company's stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of...

Connor Clark & Lunn Investment Management Ltd. Takes Position in NeoGenomics, Inc. $NEO

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the 2nd quarter, according to the company in its most recent...

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Hold" from Analysts

NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has earned a consensus recommendation of "Hold" from the sixteen research firms that are currently covering the firm, Marketbeat Ratings reports. One...

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will present new research at the International Society of Liquid Biopsy (ISLB...

NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates

NeoGenomics (NEO) delivered earnings and revenue surprises of +50.00% and +2.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

NeoGenomics Reports Third Quarter 2025 Results

NeoGenomics, Inc. (NASDAQ: NEO) (the Company), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its third quarter results for the period ended...

Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains?

Armata Pharmaceuticals (ARMP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?

NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.04	--	--	N/A
Q3 '25	$0.02	$0.03	46.07%	BEAT
Q2 '25	$0.02	$0.03	32.91%	BEAT
Q1 '25	-$0.01	$0.00	100.00%	BEAT
Q4 '24	$0.03	$0.04	40.06%	BEAT

NEO
Neogenomics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest NEO News

NEONeogenomics Inc.